In fiscal year 2025, GC Genome (340450) reported revenue of 31.5 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 31.5 billion KRW | 1.2 billion KRW | 4.0 billion KRW | [source] |
| 2024 | 25.9 billion KRW | -1.2 billion KRW | -1.3 billion KRW | — |
| 2023 | 27.3 billion KRW | 160 million KRW | -550 million KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 84.6 billion KRW | 6.4 billion KRW | 78.3 billion KRW | [source] |
| 2024 | — | — | — | — |
| 2023 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.